117 related articles for article (PubMed ID: 9045054)
1. Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D; Friend SH; Li FP; Strong LC
N Engl J Med; 1997 Mar; 336(10):734. PubMed ID: 9045054
[No Abstract] [Full Text] [Related]
2. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J
N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144
[TBL] [Abstract][Full Text] [Related]
3. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
[TBL] [Abstract][Full Text] [Related]
4. Lack of germ-line mutations in the p53 gene exons 4 to 8 in patients with late-onset second malignant neoplasms.
Lalle P; Moyret C; Bignon YJ
Cancer Genet Cytogenet; 1994 Sep; 76(2):148-50. PubMed ID: 7923066
[TBL] [Abstract][Full Text] [Related]
5. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
Menko FH; Nooy MA; Vasen HF
Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
[No Abstract] [Full Text] [Related]
6. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF
Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
8. [Predictive testing for p53-mutations; ethical considerations. National Work Group Hereditary Mamma Carcinoma].
de Wert GM
Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1350-3. PubMed ID: 8710023
[No Abstract] [Full Text] [Related]
9. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
10. Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene.
Kikuchi T; Rempel SA; Rutz HP; de Tribolet N; Mulligan L; Cavenee WK; Jothy S; Leduy L; Van Meir EG
Cancer Res; 1993 Mar; 53(5):957-61. PubMed ID: 8439970
[TBL] [Abstract][Full Text] [Related]
11. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
[TBL] [Abstract][Full Text] [Related]
12. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
Malkin D; Li FP; Strong LC; Fraumeni JF; Nelson CE; Kim DH; Kassel J; Gryka MA; Bischoff FZ; Tainsky MA
Science; 1990 Nov; 250(4985):1233-8. PubMed ID: 1978757
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog.
Veldhoen N; Stewart J; Brown R; Milner J
Oncogene; 1998 Jan; 16(2):249-55. PubMed ID: 9464543
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.
Stelljes M; Corbacioglu A; Schlenk RF; Döhner K; Frühwald MC; Rossig C; Ehlert K; Silling G; Müller-Tidow C; Juergens H; Döhner H; Berdel WE; Kienast J; Koschmieder S
Leukemia; 2011 Jul; 25(7):1209-10. PubMed ID: 21455213
[No Abstract] [Full Text] [Related]
15. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
16. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
[TBL] [Abstract][Full Text] [Related]
17. Germline TP53 mutations is common in patients with two early-onset primary malignancies.
Chak BP; Chan ES; Tong JH; Leung AW; Cheng FW; Lam GK; Shing MM; Li CK; To KF
Clin Genet; 2015 May; 87(5):499-501. PubMed ID: 25293557
[No Abstract] [Full Text] [Related]
18. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M
Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062
[TBL] [Abstract][Full Text] [Related]
19. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Zou ZQ; Pirollo K; Blattner W; Chang EH
Nature; 1990 Dec 20-27; 348(6303):747-9. PubMed ID: 2259385
[TBL] [Abstract][Full Text] [Related]
20. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
